Australia, Aug. 30 -- Iambic Therapeutics Inc., owns the trademark (2528124) for 'NEURALPLEXER' till March 6, 2035.
Status: registered:
Registered/protected
Class: 42 [Drug discovery services; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence for collecting, analyzing, interpreting and reporting data and information in the field of drug design and development; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence and machine learning for molecular docking; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence for biomolecular structure prediction; platform as a service (PAAS) featuring a compu...